The future of machine tools will be dominated by highly flexible and interconnected systems, in order to achieve the required productivity, accuracy and reliability. Nowadays, distortion and vibration problems are easily solved in labs for the most common machining operations by using models based on equations describing the physical laws of the machining processes; however additional efforts are needed to overcome the gap between scientific research and the real manufacturing problems. In fact, there is an increasing interest in developing simulation packages based on “deep-knowledge and models” that aid machine designers, production engineers or machinists to get the best of the machine-tools. This article proposes a methodology to reduce problems in machining by means of a simulation utility, which uses the main variables of the system&process as input data, and generates results that help in the proper decision-making and machining planification. Direct benefits can be found in a) the fixture/clamping optimal design, b) the machine tool configuration, c) the definition of chatter-free optimum cutting conditions and d) the right programming of cutting toolpaths at the Computer Aided Manufacturing (CAM) stage. The information and knowledge-based approach showed successful results in several local manufacturing companies and are explained in the paper.
IGF-I, insulin-like growth factor 1, is present in normal fetal/neonatal brain development and reappears in the mature brain participating in the development of malignant tumor, glioblastoma multiforme. Targeting the IGF-I system has emerged as a useful method to reduce glial malignant development. Downregulation in the expression of IGF-I using antigene anti-IGF-I technology (antisense, AS, and triple helix, TH) applied in glioma cell culture established from glioblastoma biopsies induces the expression of B7 and MHC-I antigens in transfected cells (immunogenicity). The transfected cancer cells, "vaccines," after subcutaneous injection, initiated an immune response mediated by T CD8+ lymphocytes, followed by tumor regression (immunotherapy). The median survival of patients treated by surgery followed by radiotherapy and immunotherapy was 21–24 months. On the other side, the experimental work has demonstrated that IGF-I AS or TH transfected tumor cells fused with activated dendritic cells, DC, showing more striking immunogenic character. Using IGF-I TH/DC "vaccination," the efficiency in suppressing rat glioma tumors is not only relatively higher than that obtained using IGF-I TH cells but is also more rapid.
EN LA CEREMONIA DE CELEBRACION DEL DECIMO ANIVERSARIO DE LA GENERACION 1981-1985 MAESTRA MARIA INES IZAGUIRRE ROMERO DE LA FACULTAD DE MEDICINA VETERINARIA Y ZOOTECNIA (FMVYZ), EL DIRECTOR DE ESTA DEPENDENCIA, DOCTOR LEOPOLDO PAASCH MARTINEZ, INVITO AL GRUPO DE EGRESADOS A INTERRELACIONARSE CON LA INSTITUCION QUE LOS FORMO, A TRAVES DE LA DIVISION DE EDUCACION CONTINUA, ASI COMO CON EL USO DE LOS SERVICIOS AUTOMATIZADOS DE LA BIBLIOTECA DE LA DEPENDENCIA, QUE POSEE EL BANCO DE DATOS MAS GRANDE DE LA ESPECIALIDAD EN MEXICO. A NOMBRE DE LOS EGRESADOS HABLO ALVARO ALVAREZ BARRAGAN. EN EL EVENTO, SE DEVELO UNA PLACA CONMEMORATIVA DE DICHO ANIVERSARIO.
The aim of this study was to establish the criteria for methodology of cellular "anti-IGF-I" therapy of malignant tumours and particularly for glioblastoma multiforme. The treatment of primary glioblastoma patients using surgery, radiotherapy, and chemotherapy was followed by subcutaneous injection of autologous cancer cells transfected by IGF-I antisense/triple helix expression vectors. The prepared cell "vaccines" should it be in the case of glioblastomas or other tumours, have shown a change of phenotype, the absence of IGF-I protein, and expression of MHC-I and B7. The peripheral blood lymphocytes, PBL cells, removed after each of two successive vaccinations, have demonstrated for all the types of tumour tested an increasing level of CD8(+) and CD8(+)28(+) molecules and a switch from CD8(+)11b(+) to CD8(+)11. All cancer patients were supervised for up to 19 months, the period corresponding to minimum survival of glioblastoma patients. The obtained results have permitted to specify the common criteria for "anti-IGF-I" strategy: characteristics sine qua non of injected "vaccines" (cloned cells IGF-I(-) and MHC-I(+)) and of PBL cells (CD8(+) increased level).
Este artículo muestra las ideas clave de Manuel Chaves Nogales (Sevilla, 1897– Londres, 1944) sobre el periodismo. Para ello, se han recogido los textos queescribió hablando de la profesión. Chaves Nogales fue uno de los periodistasmás destacados de la II República española. Subdirector del moderado diarioAhora, el de mayor éxito en aquella época, se tuvo que exiliar primero a París, acausa de la Guerra Civil, y después a Londres, tras la entrada de la Alemania nazien Francia. Su carácter mesurado, inequívocamente democrático y republicano,alejado de los extremos del fascismo y el comunismo, el propio de un "pequeñoburgués liberal", como él mismo se definía, propiciaron su olvido duranteaños. Solo en los últimos tiempos su obra, ejemplo de periodismo moderno,se está empezando a reeditar en España, con gran éxito de crítica y lectores
Resumen es: Esta investigacion pretende mostrar las tecnicas y los usos periodisticos que han llevado a diferentes periodistas y escritores espanoles a considerar a ...
Este artículo estudia el arte de la caracterización del periodista Manuel Chaves Nogales (Sevilla,1897 – Madrid, 1944) en una selección de sus textos periodísticos publicados en España. Se trata de 18 piezas de diferentes géneros (crónicas, semblanzas, reportajes, entrevistas) en los que la caracterización es elemento central. A través de ellos se puede observar la evolución en la caracterización de Chaves y su afán por desvelar el carácter de personajes de actualidad a través de escenas significativas, mediante unas pocas pinceladas que, indirectamente, muestran sus preocupaciones políticas, sociales y periodísticas.